Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 2
1985 1
1988 1
1989 1
1992 1
1995 2
1996 1
1998 4
1999 4
2000 2
2001 8
2002 2
2003 5
2004 6
2005 3
2006 6
2007 6
2008 6
2009 6
2010 7
2011 5
2012 4
2013 3
2014 2
2015 1
2016 3
2017 7
2018 4
2019 10
2020 6
2021 15
2022 9
2023 11
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

138 results

Results by year

Filters applied: . Clear all
Page 1
Antibiotic Prophylaxis in Infants with Grade III, IV, or V Vesicoureteral Reflux.
Morello W, Baskin E, Jankauskiene A, Yalcinkaya F, Zurowska A, Puccio G, Serafinelli J, La Manna A, Krzemień G, Pennesi M, La Scola C, Becherucci F, Brugnara M, Yuksel S, Mekahli D, Chimenz R, De Palma D, Zucchetta P, Vajauskas D, Drozdz D, Szczepanska M, Caliskan S, Lombet J, Minoli DG, Guarino S, Gulleroglu K, Ruzgiene D, Szmigielska A, Barbi E, Ozcakar ZB, Kranz A, Pasini A, Materassi M, De Rechter S, Ariceta G, Weber LT, Marzuillo P, Alberici I, Taranta-Janusz K, Caldas Afonso A, Tkaczyk M, Català M, Cabrera Sevilla JE, Mehls O, Schaefer F, Montini G; PREDICT Study Group. Morello W, et al. Among authors: zucchetta p. N Engl J Med. 2023 Sep 14;389(11):987-997. doi: 10.1056/NEJMoa2300161. Epub 2023 Sep 12. N Engl J Med. 2023. PMID: 37702442 Clinical Trial.
PET/MRI in prostate cancer: a systematic review and meta-analysis.
Evangelista L, Zattoni F, Cassarino G, Artioli P, Cecchin D, Dal Moro F, Zucchetta P. Evangelista L, et al. Among authors: zucchetta p. Eur J Nucl Med Mol Imaging. 2021 Mar;48(3):859-873. doi: 10.1007/s00259-020-05025-0. Epub 2020 Sep 8. Eur J Nucl Med Mol Imaging. 2021. PMID: 32901351 Free PMC article. Review.
Guest Editorial.
Zucchetta P. Zucchetta P. Semin Nucl Med. 2017 May;47(3):188-189. doi: 10.1053/j.semnuclmed.2017.02.002. Semin Nucl Med. 2017. PMID: 28417850 No abstract available.
Pediatric Imaging Using PET/MR Imaging.
Giraudo C, Carraro S, Zucchetta P, Cecchin D. Giraudo C, et al. Among authors: zucchetta p. Magn Reson Imaging Clin N Am. 2023 Nov;31(4):625-636. doi: 10.1016/j.mric.2023.06.001. Epub 2023 Jul 28. Magn Reson Imaging Clin N Am. 2023. PMID: 37741646 Review.
Letter From the Guest Editor.
Zucchetta P. Zucchetta P. Semin Nucl Med. 2017 Mar;47(2):100-101. doi: 10.1053/j.semnuclmed.2016.10.011. Epub 2016 Nov 23. Semin Nucl Med. 2017. PMID: 28236997 No abstract available.
[18F]FDG PET/MRI in rectal cancer.
Crimì F, Valeggia S, Baffoni L, Stramare R, Lacognata C, Spolverato G, Albertoni L, Spimpolo A, Evangelista L, Zucchetta P, Cecchin D, Pucciarelli S. Crimì F, et al. Among authors: zucchetta p. Ann Nucl Med. 2021 Mar;35(3):281-290. doi: 10.1007/s12149-021-01580-0. Epub 2021 Jan 31. Ann Nucl Med. 2021. PMID: 33517562 Free PMC article. Review.
Nuclear Medicine in Pediatric Cardiology.
Milanesi O, Stellin G, Zucchetta P. Milanesi O, et al. Among authors: zucchetta p. Semin Nucl Med. 2017 Mar;47(2):158-169. doi: 10.1053/j.semnuclmed.2016.10.008. Epub 2017 Jan 10. Semin Nucl Med. 2017. PMID: 28237004 Review.
EANM position paper: theranostics in brain tumours-the present and the future.
Tolboom N, Verger A, Albert NL, Brendel M, Cecchin D, Fernandez PA, Fraioli F, Guedj E, Herrmann K, Traub-Weidinger T, Morbelli S, Yakushev I, Zucchetta P, Barthel H, Van Weehaeghe D. Tolboom N, et al. Among authors: zucchetta p. Eur J Nucl Med Mol Imaging. 2023 Dec;51(1):202-205. doi: 10.1007/s00259-023-06425-8. Eur J Nucl Med Mol Imaging. 2023. PMID: 37698647 No abstract available.
Impact of minimal residual disease standardised assessment by FDG-PET/CT in transplant-eligible patients with newly diagnosed multiple myeloma enrolled in the imaging sub-study of the FORTE trial.
Zamagni E, Oliva S, Gay F, Capra A, Rota-Scalabrini D, D'Agostino M, Belotti A, Galli M, Racca M, Zambello R, Gamberi B, Albano D, Bertamini L, Versari A, Grasso M, Sgherza N, Priola C, Fioritoni F, Patriarca F, De Cicco G, Villanova T, Pascarella A, Zucchetta P, Tacchetti P, Fanti S, Mancuso K, Barbato S, Boccadoro M, Musto P, Cavo M, Nanni C. Zamagni E, et al. Among authors: zucchetta p. EClinicalMedicine. 2023 Jun 9;60:102017. doi: 10.1016/j.eclinm.2023.102017. eCollection 2023 Jun. EClinicalMedicine. 2023. PMID: 37396807 Free PMC article.
138 results